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Abstract
In this paper, we construct a model to describe the transmission
of HIV in a homogeneous host population. By considering the specific
mechanism of HIV, we derive a model structured in three successive
stages: (i) primary infection, (ii) long phase of latency without symp-
toms and (iii) AIDS. Each HIV stage is stratified by the duration
for which individuals have been in the stage, leading to a continu-
ous age-structure model. In the first part of the paper, we provide
a global analysis of the model depending upon the basic reproduc-
tion number R0. When R0 ≤ 1, then the disease-free equilibrium
is globally asymptotically stable and the infection is cleared in the
host population. On the contrary, if R0 > 1, we prove the epidemic’s
persistence with the asymptotic stability of the endemic equilibrium.
By performing the sensitivity analysis, we then determine the impact
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of control-related parameters of the outbreak severity. For the second
part, the initial model is extended with intervention methods. By tak-
ing into account ART interventions and the probability of treatment
drop out, we discuss optimal interventions methods which minimize
the number of AIDS cases.
Keywords: HIV, ART, Age structure, Non-linear dynamical system, Sta-
bility, Optimal control
MSC2010: 35Q92, 49J20, 35B35, 92D30
1 Introduction
Biology and evolution of HIV infection. The human immunodefi-
ciency virus (HIV) is a virus that attacks the immune system, the body’s
defense against infections. HIV weakens your immune system by destroying
cells that are essential for fighting diseases and infections. Without treat-
ment, the immune system becomes too weak. A chronic progressive disease
called AIDS (Acquired Immunodeficiency Syndrome) then appears. The sit-
uation of the epidemic in the world shows only a stabilization of the number
of new cases diagnosed, although undeniable efforts have been made in recent
years [41]. The complexity of HIV infection is linked to many elements that
particularly involve the specific mechanism of infection [20]. In the absence
of treatment, the HIV infection goes through three successive stages corre-
sponding to T4 cell count ranges: (i) primary infection, (ii) long phase of
latency without symptoms, and (iii) AIDS [44]. Primary infection: The risk
of transmission is particularly high during this phase because of the high viral
load at this stage of the infection [43, 19, 32]. This stage is characterized by
occurrence of symptoms similar to those of a cold or a mild influenza (fever,
rashes, fatigue, headaches) which disappear spontaneously after few weeks
[1, 43]. Phase of latency without symptoms: Generally, HIV-positive people
do not experience any particular problem at this stage for many years and
can lead normal lives, although the virus is spreading insidiously in the body
and permanently mistreats the immune system [1, 43]. AIDS stage: Because
of its constant solicitation, the immune system becomes weaker and weaker
until it can no longer defend itself against many pathogens agent and prevent
the occurrence of serious or fatal diseases [1, 43].
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Waiting time within HIV infection stages. Staged progression mod-
els have been proposed to investigate the transmission dynamics of HIV
[31, 25, 21, 31, 29, 18, 17, 12, 45]. Here, we go through the same direction
by modeling the progression through three HIV stages described previously
(which are enough for the practical interpretation of the HIV stages up to
date). However, none of the aforementioned works deal with a continuous
stage-structured model as in the context of this work. Indeed, here we con-
sider the duration a ≥ 0 spent in a given HIV stage as a continuous variable
(not to be confused with the time since infection as in [35], or with age-
group such as ”youths”, ”adults”, etc). Further, our model formulation is
well adapted for the dynamics of HIV infection without any treatment: ref-
erence values for duration of HIV stages 1 and 2 are 2.90 (range 1.23-6) and
120 (range 108-180) months respectively [19]. Moreover, the model proposed
here is suitable for the specific mechanisms of antiretroviral therapy, ART
for short, which is the use of HIV medicines to slow down the progress of the
infection. In fact, ART help people with HIV live longer by extending the
time spent in a given HIV stage [2].
The model. Here we formulate a model structured by the duration a for
which individuals have been in a given HIV stage. The model is called
age-structured model thereafter. The host population is divided into four
compartments: S(t) denotes the density of susceptible individuals at time
t, while i1(t, a), i2(t, a) and i3(t, a) respectively denote the density of the
primary infected, infected in asymptomatic stage and infected in AIDS stage
at time t who have been in that stage for duration a > 0 (the time spent in
the stage). The transfer diagram reads:
The parameter Λ represents the positive contribution entering into the
susceptible population and µ is the natural death rate of susceptible individ-
uals. The function β = β(a) is the rate of being infectious after a time a
within HIV stage 1, ε > 0 and δ ≥ 0 are the reduced transmission rate in
HIV stages 2 and 3. The death rate of infectious individuals i1, i2 and i3,
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are respectively denoted by functions d1 = d1(a), d2 = d2(a) and d3 = d3(a).
Obviously, infectious individuals are assumed to have an increased rate of
death (i.e. dj ≥ µ). The rate of the disease progression from infectious class
i1 to the infectious class i2 is γ1 = γ1(a), as well as γ2 = γ2(a) the rate of
progression from infectious class i2 to the infectious class i3.
The model we shall consider in this work reads as the following age struc-
tured system of equations,
S˙(t) = Λ− µS(t)− S(t)
P (t)
∫∞
0
β(a) (i1(t, a) + εi2(t, a) + δi3(t, a)) da,
i1(t, 0) =
S(t)
P (t)
∫∞
0
β(a) (i1(t, a) + εi2(t, a) + δi3(t, a)) da,
(∂t + ∂a) i1(t, a) = − (γ1(a) + d1(a)) i1(t, a),
i2(t, 0) =
∫∞
0
γ1(a)i1(t, a)da,
(∂t + ∂a) i2(t, a) = − (γ2(a) + d2(a)) i2(t, a),
i3(t, 0) =
∫∞
0
γ2(a)i2(t, a)da,
(∂t + ∂a) i3(t, a) = −d3(a)i3(t, a),
with
P (t) = S(t) +
∫∞
0
(i1(t, a) + i2(t, a) + i3(t, a)) da,
(1.1)
coupled with the initial condition
S(0) = S0, i1(0, a) = i10(a), i2(0, a) = i20(a), i3(0, a) = i30(a). (1.2)
Furthermore, model parameters are assumed to satisfy the following hy-
potheses:
Assumption 1.1 :
1. Λ, µ > 0; β, d1, d2, d3, γ1, γ2,∈ L∞+ (0,∞) and dj(·) ≥ µ.
2. β and γj are Lipschitz continuous almost everywhere on R+.
3. For any a > 0, there exists a(β); a(γj) > a, with j = 1, 2, 3; such
that β is positive in a neighbourhood of a(β) and γj is positive in a
neighbourhood of a(γj).
Aims. In the first part of this article we shall study some dynamical prop-
erties of problem (1.1)-(1.2). We shall first compute the basic reproduction
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number which determines the outcome of the disease and study the stabil-
ity of the model equilibria. We shall perform the global sensitivity analysis
of the HIV late stage. That is to help us know parameters that are most
influential in determining disease dynamics, i.e. AIDS cases.
In the second part of this article, we then introduce intervention strategies
into model (1.1) aiming to optimally reduce AIDS cases in the host popula-
tion. Several HIV intervention options (called controls) do exist. Individuals
do not take the same combination of medicines because the infection stages
differ [2]. Therefore, interventions strategies introduce in the model of this
note are stage specific. Furthermore, there have been numerous works on
optimal control of age-structured populations [3, 7, 4, 16, 24, 9, 8, 13, 15, 30]
and references cited therein.
This paper is organized as follows. Section 2 describes preliminaries re-
sults of model (1.1): existence of semiflow and asymptotic behaviour. We
derive the global sensitivity analysis, describe model parameters and the typ-
ical model simulation in Section 3. In Section 4, we extend model (1.1) with
intervention strategies and characterize the necessary optimality condition.
We then discuss the effectiveness of those interventions and some model hy-
pothesis and limitations in Section 5. Sections 6-8 are devoted to proofs of
our main results.
2 Preliminaries
The aim of this section is to provide some preliminary remarks to system
(1.1). Let us introduce the following notations, for a ≥ 0,
D3(a) = exp
(
−
∫ a
0
(d3(σ)) dσ
)
, Dj(a) = exp
(
−
∫ a
0
(γj(σ) + dj(σ)) dσ
)
; j = 1, 2,
Dj =
∫ ∞
0
Dj(a)da, Ωj =
∫ ∞
0
β(σ)Dj(σ)dσ; j = 1, 2, 3,
Γj =
∫ ∞
0
γj(σ)Dj(σ)dσ; j = 1, 2.
2.1 Existence of semiflow
We first formulate system (1.1) composed by (S, i1, i2, i3) in an abstract
Cauchy problem. For that aim, we introduce the Banach space X = R ×
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R3 ×L1(0,∞,R3) endowed with the usual product norm ‖ · ‖X as well as its
positive cone X+. Let A : D(A) ⊂ X → X be the linear operator defined by
D(A) = R× {0R3} ×W 1,1(0,∞,R3) and
A (v, 0, 0, 0, u1, u2, u3)
T =

−µv
−u1(0)
−u2(0)
−u3(0)
−u′1 − (γ1 + d1)u1
−u′2 − (γ2 + d2)u2
−u′3 − d3u3

.
Finally, let us introduce the non-linear map F : D(A)→ X defined by
F (v, 0, 0, 0, u1, u2, u3)
T =

Λ− v
v+
∑3
j=1
∫∞
0 uj(a)da
∫∞
0
β(a) (u1(a) + εu2(a) + δu3(a)) da
v
v+
∑3
j=1
∫∞
0 uj(a)da
∫∞
0
β(a) (u1(a) + εu2(a) + δu3(a)) da∫∞
0
γ1(a)u1(a)da∫∞
0
γ2(a)u2(a)da
0
0
0

.
By identifying ϕ(t) together with (S(t), 0R3 , i1(t, .), i2(t, .), i3(t, .))
T and
by setting ϕ0 = (S0, 0R3 , i10(.), i20(.), i30(.))
T , system (1.1) rewrites as the
following Cauchy problem
dϕ(t)
dt
= Aϕ(t) + F (ϕ(t)),
ϕ(0) = ϕ0.
(2.3)
By setting X0 = D(A) and X0+ = X0 ∩ X+ the precise result is the
following theorem.
Theorem 2.1 Let Assumption 1.1 be satisfied. Then there exists a unique
strongly continuous semiflow {Φ(t, ·) : X0 → X0}t≥0 such that for each ϕ0 ∈
X0+, the map ϕ ∈ C ((0,∞),X0+) defined by ϕ = Φ(·, ϕ0) is a mild solution
of (2.3), namely, it satisfies
∫ t
0
ϕ(s)ds ∈ D(A) and ϕ(t) = ϕ0 +A
∫ t
0
ϕ(s)ds+∫ t
0
F (ϕ(s)) ds for all t ≥ 0. Moreover, {Φ(t, ·)}t satisfies the following prop-
erties:
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1. Let Φ(t, ϕ0) = (S(t), 0R3 , i1(t, ·), i2(t, ·), i3(t, ·))T ; then the following Volterra
formulation holds true
i1(t, a) =
{
i10(a− t) D1(a)D1(a−t) , for t < a,
S(t−a)
P (t−a)E1(t− a)D1(a), for t ≥ a
(2.4)
ij(t, a) =
{
ij0(a− t) Dj(a)Dj(a−t) , for t < a,
Ej(t− a)Dj(a), for t ≥ a,
j = 2, 3;
wherein
E1(t) =
∫ ∞
0
β(a) (i1(t, a) + εi2(t, a) + δi3(t, a)) da, and
Ej+1(t) =
∫ ∞
0
γj(a)ij(t, a)da, j = 1, 2.
(2.5)
2. For all ϕ0 ∈ X0+ one has for all t ≥ 0,
‖Φ(t, ϕ0)‖X ≤ max
{
Λ
µ
,
Λ
µ
+ e−µt
(
‖ϕ0‖X − Λ
µ
)}
≤ max
{
Λ
µ
, ‖ϕ0‖X
}
.
3. The semiflow {Φ(t, ·)}t is bounded dissipative and asymptotically smooth.
4. There exists a nonempty compact set B ⊂ X0+ such that
(i) B is invariant under the semiflow {Φ(t, ·)}t.
(ii) The subset B attracts the bounded sets of X0+ under the semi-
flow {Φ(t, ·)}t.
We refer to Section 6 for the proof of Theorem 2.1.
2.2 Basic reproduction number and asymptotic behaviour
An equilibrium (S, i1(a), i2(a), i3(a)) of system (1.1) is such that ij(a) =
Dj(a)ij(0), with j = 1, 2, 3; and
i1(0) =
S
P
(i1(0)Ω1 + εi2(0)Ω2 + δi3(0)Ω3) ,
i2(0) = Γ1i1(0),
i3(0) = Γ2i2(0),
i1(0) = Λ− µS,
P = S +
∑3
j=1Djij(0).
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The disease-free equilibrium corresponds to i1(0) = i2(0) = i3(0) = 0 and is
given by E0 =
(
Λ
µ
, 0, 0, 0
)
.
In order to find any endemic equilibria, we first determine the basic re-
production number R0 using the next generation operator approach [10, 23].
We calculate (see Section 9)
R0 = Ω1 + εΩ2Γ1 + δΩ3Γ1Γ2.
Now by taking ij(0)’s positive, by straightforward algebra, the disease-
endemic equilibrium E∗ = (S∗, i∗1(·), i∗2(·), i∗3(·)) is such that
S∗ =
I∗0D
R0 − 1; i
∗
1(·) = I∗0D1(·); i∗2(·) = I∗0 Γ1D2(·); i∗3(·) = I∗0 Γ1Γ2D3(·),
with D = D1 +Γ1D2 +Γ1Γ2D3 and I
∗
0 =
Λ(R0−1)
µD+R0−1 . From where, the following
proposition summarizes the equilibria of the model.
Proposition 2.2 Let Assumption 1.1 be satisfied. Then the semiflow {Φ(t, ·)}t
provided by Theorem 2.1 has exactly:
(i) One equilibrium, the disease-free equilibrium E0, if R0 ≤ 1.
(i) Two equilibria, the disease-free equilibrium E0 and disease-endemic
equilibrium E∗, if R0 > 1.
We end this section by providing the following result concerning the
asymptotic behaviour of model (1.1) with respect to the R0.
Theorem 2.3 Let Assumption 1.1 be satisfied.
1. The disease-free equilibrium E0 is globally asymptotically stable if R0 <
1 and unstable if R0 > 1.
2. When R0 > 1, then
(i) The disease-endemic equilibrium E∗ is locally asymptotically
stable for {Φ(t, ·)}t.
(ii) If the initial conditions y0 satisfy i10 = i20 = i30 = 0, then
the semiflow {Φ(t, y0)}t tends to the disease-free equilibrium E0 for the
topology of X .
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(iii) If the initial conditions y0 satisfy i10 + i20 + i30 > 0, then
the semiflow {Φ(t, y0)}t is uniformly persistent in the sense that there
exists ν > 0 such that
lim inf
t→∞
∫ ∞
0
β(a) (i1(t, a) + εi2(t, a) + δi3(t, a)) da ≥ ν.
We refer to Section 7 for the proof of Theorem 2.3.
3 Model parameters, Typical model simula-
tion and Sensitivity analysis
3.1 Setting model parameters
In this section we briefly describe the shape and the values of parameters
consider for the simulations of model (1.1). For all simulations, parameters
Λ and µ are assumed to be fixed with constant values given in Table 1. We
also assume that the disease induced mortality for HIV stage j, dj(a), is
constant with respect to the duration within the stage (i.e. dj(a) ≡ dj) and
the fixed reference value is given in Table 1. Therefore, we more specifically
describe the duration-dependent parameters β(a) and γj(a).
Transmission rate β. The parameter β is defined for each stage of infec-
tion as in [19, 12]. For simplicity, we assume that individuals with AIDS do
not substantially contribute in further spread of HIV (i.e., not risky sexual
behavior) such that we can set δ = 0. The transmission rate is assumed to
be constant for each stage of infection. During stage j, the transmission rate
is ρ0 × βj with j = 1, 2. Here, ρ0 > 0 is the rate at which an infectious
individual infects the susceptible individuals, and βj’s are transmission haz-
ard. As pointed in [19, 12], HIV is 26 times more infectious during stage
1 than during stage 2. For simulations, the reference values and range of
parameters β1 and β2 are given in Table 1. Further, we set the transmission
rate ρ0 ' 2.48, such that the maximum value of R0 for the set of variation
of parameters is 7.
Rate of progression from HIV stage j to stage j + 1, γj(a). The
parameter γj is set to
γj(a) = 0 if a < T
j
0 and γ¯j if a ≥ T j0 ;
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wherein T j0 is the duration of the j-stage of HIV infection and γ¯j = 1 is the
constant progression rate. Infected individuals in stage j remain in that stage
for a period of time T j0 and then progress to stage j+ 1 at a constant rate γ¯j
after the duration of the stage T j0 . For simulations, the reference values and
the range of parameters γ¯j and T
j
0 are given in Table 1.
3.2 Typical epidemic dynamics simulated with the model
For all simulations consider in this note, we assume that the initial susceptible
population is S(0) = Λ/µ and the initial distribution of infectives are i10(a) =
c01l10(a), i20(a) = c02l20(a) and i30(a) = 0 for all a ≥ 0 (in months) with
l10(a) =
{
e−µa, a ≤ 2.9,
e−µ(2a−2.9), a > 2.9
l20(a) =
{
e−µa, a ≤ 120,
e−µ(2a−120), a > 120.
By setting N0 = S(0)+‖i10‖L1 +‖i20‖L1 , the constants c01 and c02 are scaling
coefficients given by c01 =
0.025N0
100‖l10‖L1
and c02 =
0.025N0
100‖l20‖L1
such that the HIV
epidemic is initialized with a disease prevalence of
‖i10‖L1+‖i20‖L1
N0
× 100 =
0.05%.
Numerical simulations of Figure 1 are based on the reference values of the
model parameters defined previously and summarized in Table 1. For those
parameter values, R0 = 2.55 and the dynamics of susceptible, S(t), and the
total number of HIV stage j, Ij(t) =
∫∞
0
ij(t, a)da with j = 1, 2, 3, at time
t are given in Figure 1. Furthermore, the total number of HIV late stage
I3 is always be zero in the first 120 months (Figure 1, right-bottom). This
behaviour is explained by the fact that, in Figure 1, the duration of HIV
stage 2 is set 120 months and the initial population in HIV late stage is set
to zero (i30(a) ≡ 0).
3.3 Global sensitivity analysis
Global sensitivity analyses [33] quantify the relative importance of model pa-
rameters by partitioning the variance of output variables into those resulting
from the main effects of parameters and their higher-order interactions. Here
we study the sensitivity of the HIV late stage I tot3 =
∫ T
0
∫∞
0
i3(t, a)dadt to the
four parameters γ1(·), γ2(·), β1 and β2. The range of variation accounting for
the known biological variability of above parameters is assigned in Table1.
Actually, the variability of γj(·) is determined by the one of T j0 (see Section
10
Figure 1: Typical epidemics simulated by the model. Parameters of the
model are set to their reference values given in Table 1 leading to R0 = 2.55.
The figure illustrates the dynamics of susceptible, S(t), and the total number
of HIV stage j, Ij(t) =
∫∞
0
ij(t, a)da, at time t. For each figure, the dot line
represents the endemic equilibrium of the model.
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Transmission proba.
 of stage 2
HIV progression rate:
 stage 1 to 2
Transmission proba.
 of stage 1
HIV progression rate:
 stage 2 to 3
% of variance explained
0 20 40 60 80 100
Sensitivity indices of the HIV late stage
Main effect
Other interactions
Figure 2: Sensitivity
indices of the HIV
late stage I tot3 =∫ T
0
∫∞
0
i3(t, a)dadt.
The black parts of bars
correspond to the main
indices (effect of the
factor alone) and full
bars correspond to total
indices (white parts cor-
responds to the effect of
the factor in interaction
with all other factors).
3.1). Sensitivity indices is estimated by fitting an ANOVA (Analysis of vari-
ance) linear model, including third-order interactions, to the data generated
by simulation. Note that this ANOVA linear model fitted very well with 99%
of variance explained. The model is implement with MatLab software and
the ANOVA analysis with R software (http://www.r-project.org/). Sensitiv-
ity analyses indicate that the HIV progression rate from stage 2 to 3 (γ2) is
the most influential factor of the HIV late stage I tot3 (79% of the variance,
Figure 2). The next factor, the transmission rate of stage 1 (β1) accounting
for 8% of the variance, is followed by the HIV progression rate from stage 1
to 2 (γ1) and the transmission rate of stage 2 (β2) (<5% of variance explained
for each).
4 Optimal intervention strategies
Today, more tools are available to prevent HIV such as using condoms
the right way every time you have sex or by taking newer HIV prevention
medicines such as pre-exposure prophylaxis and post-exposure prophylaxis
[5]. But, when living with HIV, up to date, the most important intervention
is taking medicines to treat HIV (called ART). Although a cure for HIV does
not yet exist, ART can keep healthy for many years if taken consistently and
correctly and greatly reduce the chance of transmitting to a partners. Those
options are supported by the sensitivity analysis: (i) prevention methods, by
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the HIV transmission rates and (ii) treatment of HIV, by the HIV progression
rates (Figure 2). However, only ART is consider as an intervention strategy
in this note.
4.1 Extended model with intervention methods
In addition to the previous state variables, S(t)-susceptible, i1(t, a)-HIV stage
1 (who are not under ART) and i2(t, a)-HIV stage 2 (who are not under
ART), ART interventions induced four additional state variables: i1,TF (t, a)-
HIV stage 1 and i2,TF (t, a)-HIV stage 2 with ART failure or drop out, as
well as i1,TS(t, a)-HIV stage 1 and i2,TS(t, a)-HIV stage 2 with ART success.
We also introduce the probability of treatment drop out: p1; at HIV stage
1, p2, at HIV stage 2 (with no ART at HIV stage 1) and p2,TF , at HIV
stage 2 (with ART drop out at HIV stage 1). This differential infectivity is
supported by the fact that individuals who have dropped out of treatment
progress through subsequent HIV stages twice as fast as treatment-na¨ıve in-
dividuals [12]. Therefore, people in class i1,TF (resp. i2,TF ) progress at rate
γ1,TF (a) (resp. γ2,TF (a)) to the HIV stage 2 (resp. late stage). Then, the
force of infection and overall progression into subsequent stages write E1(t) =∫∞
0
β(a) [i1 + i1,TF + ε(i2 + i2,TF ) + δi3] (t, a)da, E2(t) =
∫∞
0
γ1(a)i1(t, a)da,
E2,TF (t) =
∫∞
0
γ1,TF (a)i1,TF (t, a)da, and E3(t) =
∫∞
0
(γ2(a)i2(t, a) + γ2,TF (a)i2,TF (t, a)) da.
The total population is set to P (t) = S(t)+
∑3
j=1
∫∞
0
ij(t, a)da+
∑2
j=1
∫∞
0
ij,TF (t, a)da+∑2
j=1
∫∞
0
ij,TS(t, a)da. The transfer diagram of the model becomes:
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Three interventions strategies, called controls, are include into our initial
model (1.1). Controls are represented as functions of time and assigned
reasonable upper and lower bounds. At a time t, we define the proportion of
individuals: (i) h1(t); under ART at HIV stage 1, (ii) h2(t), under ART at
HIV stage 2 (which were not under ART at HIV stage 1) and (iii) h2,TF (t),
under ART at HIV stage 2 (with ART drop out at HIV stage 1). Then, the
system describing our model with controls writes
S˙(t) =Λ− µS(t)− S(t)E1(t)/P (t),
(∂t + ∂a) i1(t, a) =− (γ1(a) + d1(a)) i1(t, a),
(∂t + ∂a) i1,TF (t, a) =− (γ1,TF (a) + d1(a)) i1,TF (t, a),
(∂t + ∂a) i1,TS(t, a) =− d1(a)i1,TS(t, a),
(∂t + ∂a) i2(t, a) =− (γ2(a) + d2(a)) i2(t, a),
(∂t + ∂a) i2,TF (t, a) =− (γ2,TF (a) + d2(a)) i2,TF (t, a),
(∂t + ∂a) i2,TS(t, a) =− d2(a)i2,TS(t, a),
(∂t + ∂a) i3(t, a) =− d3(a)i3(t, a),
(4.6)
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with the boundary conditions
i1(t, 0) = (1− h1(t))S(t)E1(t)/P (t),
i1,TF (t, 0) =p1h1(t)S(t)E1(t)/P (t),
i1,TS(t, 0) =(1− p1)h1(t)S(t)E1(t)/P (t),
i2(t, 0) = (1− h2(t))E2(t) + (1− h2,TF (t))E2,TF (t),
i2,TF (t, 0) =p2h2(t)E2(t) + p2,TFh2,TF (t)E2,TF (t),
i2,TS(t, 0) =(1− p2)h2(t)E2(t) + (1− p2,TF )h2,TF (t)E2,TF (t),
i3(t, 0) =E3(t).
(4.7)
We set Sh(t), and yh(t, a) =(
ih1(t, a), i
h
1,TF (t, a), i
h
2(t, a), i
h
2,TF (t, a), i
h
3(t, a), i
h
1,TS(t, a), i
h
2,TS(t, a)
)T
the solu-
tion of (4.6)-(4.7) associated to the control scheme h = (h1, h2, h2,TF )
T .
To illustrate the dependency with respect to h, we also set P h(t) = P (t),
Eh1 (t) = E1(t), E
h
2 (t) = E2(t), E
h
2,TF (t) = E2,TF (t), and E
h
3 (t) = E3(t).
Then, problem (4.6)-(4.7) rewrites
S˙h(t) = gS
(
Sh(t), Eh1 (t)/P
h(t)
)
,
(∂t + ∂a) y
h(t, a) = f(a)yh(t, a),
yh(t, 0) = φ
(
h(t), Eh1 (t)/P
h(t), Eh2 (t), E
h
2,TF (t), E
h
3 (t), E
h
3,TF (t)
)
,
(4.8)
wherein gS is given by the right-hand side of (4.6) for the S-compartment;
f(a)yh is the linear operator given by the the right-hand side of (4.6) for
the (i1, i1,TF , i2, i2,TF , i3, i1,TS, i2,TS)-compartment and φ is given by the the
right-hand side of (4.7) for the (i1, i1,TF , i2, i2,TF , i3, i1,TS, i2,TS)-compartment.
4.2 Optimal control problem
We assume that a successful scheme is one which reduces the progression to
the AIDS stage. Therefore, the control scheme is optimal if it minimizes the
objective functional
J(h) =
∫ Tf
0
∫∞
0
B(a) [γ2(a)i2(t, a) + γ2,TF (a)i2,TF (t, a)] dadt
+
∫ Tf
0
[C1h
2
1(t) + C2h
2
2(t) + C3h
2
2,TF (t)]dt
where B and Cj are balancing coefficients transforming the integral into cost
expended over a finite period of Tf months, see Table 1. The first integral,
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multiply by B, is the economic losses from individuals progressing into AIDS
stage and the second integral represents the costs for the implementation
of three controls. Quadratic expressions of controls are included to indicate
non-linear costs potentially arising at high treatment levels.
Our aim is to find h∗ satisfying
J(h∗) = min
h∈U
J(h), (4.9)
on the set
U =
{
h ∈ L∞(0, Tf ) : 0 ≤ h1(·) ≤ hmax1 ; 0 ≤ h2(·) ≤ hmax2 ;
0 ≤ h2,TF (·) ≤ hmax2,TF
}
,
where hmaxj ≤ 1 are positive measurable functions.
4.3 The necessary optimality condition
In order to deal with the necessary optimality conditions, we use some results
in Feichtinger et al. [15]. For a given solution S(t), y(t, a) =
(i1, i1,TF , i2, i2,TF , i3, i1,TS, i2,TS) (t, a) and (E1(t)/P (t), E2(t), E2,TF (t), E3(t))
of (4.6)-(4.7), we introduce the following adjoint functions λS(t), ξ(t, a) =
(λi1 , λi1,TF , λi2 , λi2,TF , λi3 , λi1,TS , λi2,TS)(t, a) and (ζ1(t), ζ2(t), ζ2,TF (t), ζ3(t)).
The following system holds from [15]
λ˙S(t) =
[
E1(t)/P (t) + µ
]
λS(t),
(∂t + ∂a)λi1(t, a) = [γ1(a) + d1(a)]λi1(t, a)− β(a)ζ1(t)/P (t)− γ1(a)ζ2(t),
(∂t + ∂a)λi1,TF (t, a) = [γ1,TF (a) + d1(a)]λi1,TF (t, a)− β(a)ζ1(t)/P (t)− γ1,TF (a)ζ2,TF (t),
(∂t + ∂a)λi2(t, a) = −Bγ2(a) + [γ2(a) + d2(a)]λi2(t, a)− εβ(a)ζ1(t)/P (t)− γ2(a)ζ3(t),
(∂t + ∂a)λi2,TF (t, a) = −Bγ2,TF (a) + [γ2,TF (a) + d2(a)]λi2,TF (t, a)
−εβ(a)ζ1(t)/P (t)− γ2,TF (a)ζ3(t),
(∂t + ∂a)λi3(t, a) = d3(a)λi3(t, a)− δβ(a)ζ1(t)/P (t),
(∂t + ∂a)λi1,TS(t, a) = d1(a)λi1,TS ,
(∂t + ∂a)λi2,TS(t, a) = d2(a)λi2,TS ,
ζ1(t) = (1− h1(t))S(t)λi1(t, 0) + p1h1(t)S(t)λi1,TF (t, 0)
+(1− p1)h1(t)S(t)λi1,TS(t, 0),
ζ2(t) = (1− h2(t))λi2(t, 0) + p2h2(t)λi2,TF (t, 0) + (1− p2)h2(t)λi2,TS(t, 0),
ζ2,TF (t) = (1− h2,TF (t))λi2(t, 0) + p2,TFh2,TF (t)λi2,TF (t, 0)
+(1− p2,TF )h2,TF (t)λi2,TS(t, 0),
ζ3(t) = λi3(t, 0),
(4.10)
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with the boundary conditions
λS(Tf ) = 0, λv(Tf , a) = 0, for v ∈ {i1, i1,TF , i2, i2,TF , i3, i1,TS, i2,TS} and for all a > 0.
(4.11)
The Hamiltonian of System (4.6)-(4.7) is given by
H(t, h) = ξ(t, 0)·φ (h,E1/P,E2, E2,TF , E3)+λS(t)gS(t)+L0(t)+
∫ ∞
0
L(t, a)da,
where L and L0 are the first and second integrand of J respectively.
Moreover, if h∗ is a solution of (4.9), then it is characterized by
h∗1(t) = max(0,min(hˆ1(t), h
max
1 )),
h∗2(t) = max(0,min(hˆ2(t), h
max
2 )),
h∗2,TF (t) = max(0,min(hˆ2,TF (t), h
max
2,TF )),
(4.12)
wherein
hˆ1(t) =
(
λi1(t, 0)− p1λi1,TF (t, 0)− (1− p1)λi1,TS(t, 0)
)
S(t)E1(t)/P (t)
2C1
,
hˆ2(t) =
(
λi2(t, 0)− p2λi2,TF (t, 0)− (1− p2)λi2,TS(t, 0)
)
E2(t)
2C2
,
hˆ2,TF (t) =
(
λi2(t, 0)− p2,TFλi2,TF (t, 0)− (1− p2,TF )λi2,TS(t, 0)
)
E2,TF (t)
2C3
.
The value function hˆ1 is obtained from equation
∂H
∂h1
= 0, using the
boundary condition whenever 0 ≤ h∗1(t) ≤ hmax1 , and similarly for hˆ2 and
hˆ2,TF . The proof of the existence of such controls is given in Section 8.
The state system (4.6)-(4.7) and the adjoint system (4.10)-(4.11) together
with the control characterization (4.12) form the optimality system to be
solved numerically. Since the state equations have initial conditions and the
adjoint equations have final time conditions, we cannot solve the optimal-
ity system directly by only sweeping forward in time. Thus, an iterative
algorithm, ”forward-backward sweep method”, is used (see [24]).
5 Discussion
For all simulations consider in this section, in addition to the parameter
reference values given by Table 1, the number of months for the strategy
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deployment is Tf = 420 (35 years). Moreover, the progression rate in classes
i1,TF and i2,TF , γ1,TF (a) and γ2,TF (a), have the same shape as γ1(a) and γ2(a)
define in Section 3.1. However, the duration of each stage i1,TF and i2,TF is
T 10 /2 and T
2
0 /2 respectively [12]. At the beginning of intervention strategies,
initial condition of state variables i1, i2 and i3 is the same as in Section 3.2.
Furthermore, we set i1,TS(0, a) = i1,TF (0, a) = i2,TS(0, a) = i2,TF (0, a) = 0
for all a ≥ 0.
Performance of controls strategies. The performance is estimated by
assessing the total number of AIDS cases during T months relatively to AIDS
cases without any strategy. Formally, the performance of the intervention
strategy h = (h1, h2, h2,TF ) is
∆h(P ) =
∫ T
0
∫∞
0
i3(t, a)
∣∣
h
dadt∫ T
0
∫∞
0
i3(t, a)
∣∣
h=0
dadt
,
wherein P = (p1, p2, p2,TF ). ∆
h(P ) provides an estimate of the number of
AIDS obtained with the control h (
∫ ∫
i3(t, a)
∣∣
h
dadt) relatively to the number
of AIDS that would have been obtained without any control (
∫ ∫
i3(t, a)
∣∣
h=0
dadt).
For example, ∆h(P ) = 0.3 indicates that the number of AIDS with control is
1/0.3 ≈ 3 times smaller than without control. However, a value of ∆h(P ) > 1
indicates that intervention strategy has negative impact on the epidemics
outbreak.
Figure 3 illustrates the effect of intervention strategies on the number
of AIDS, Itot3 (t) =
∫∞
0
i3(t, a)da. Parameters of the model are set to their
reference values given in Table 1 leading to R0 = 2.55 (without controls)
and we also set p1 = p2 = p2,TF = 10%. Optimal three-part intervention
strategies, h1, h2 and h2,TF , provide considerable reductions in the severity
of the projected outbreaks (Figure 3). Indeed, the performance of controls is
∆h(P ) ≈ 0.018, meaning that the total number of AIDS cases with controls
is 55 times smaller than without controls.
Effect of intervention only at HIV stage 1 or 2. Notice that the op-
timal control problem can be formulated to find the optimal strategy of each
HIV stage intervention method when used alone. Moreover, without any
intervention at HIV stage 1, the only plausible intervention at stage 2 is h2.
The control h1 alone has a significant effect on the epidemic outbreaks with
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Figure 3: Effect of intervention strategies on the number of AIDS, Itot3 (t) =∫∞
0
ij(t, a)da. (Left) Intervention strategies h1, h2 and h2,TF with respect
to the time t. (Right) The dynamics of the number of AIDS cases with
and without controls. Parameters of the model are set to their reference
values given in Table 1 leading to R0 = 2.55 (without controls). We also set
p1 = p2 = p2,TF = 10%.
a performance ∆h1(p1) ≤ 0.2 when the probability of treatment drop out at
HIV stage 1 p1 ranges from 0 to 80% in the host population. In other words,
for p1 ≤ 0.8, the total number of AIDS cases with controls h1 is, at least, 5
times smaller than without controls. See Figure 4. The control h2 alone has
a significant effect on the epidemic outbreaks only when the probability of
treatment drop out at HIV stage 2, p2 (with not ART at stage 1) is very small
(p2 < 0.1). The performance ∆
h2(p2) increases linearly with the value of p2
and crosses the unity around p2 = 10%, after what the intervention strategy
will have a negative effect on the epidemic outbreaks in the host popula-
tion, Figure 4. Therefore, before introducing ART, investigations should be
addressed to know whether the host population is well sensibilized on ART
treatment or not. These investigations will probably help in reducing the
probability of treatment drop out.
Combined effect of intervention at both HIV stages. Controls h1
and h2,TF have a significant effect on the disease outbreak with the perfor-
mance of both controls ∆h1,h2,TF (p1, p2,TF ) < .5, when the probability of
treatment drop out at HIV stage 1, p1 ≤ 60% and what ever the proba-
bility of treatment drop out at HIV stage 2 (with ART failure at stage 1),
p2,TF ∈ (0, 1). See Figure 5(Left). However, for high values of p1 (p1 > .6)
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Figure 4: Performance of HIV
intervention strategy when used
alone. (Dotted line) Perfor-
mance of HIV stage 1 interven-
tion alone ∆h1(p1) with respect
to the probability of ART drop
out at stage 1, p1. (Solid line)
Performance of HIV stage 2 in-
tervention alone ∆h2(p2) with
respect to the probability of
ART drop out at stage 2, p2
(with no ART at stage 1).
and for p2,TF > .2, both controls have a negative effect on the epidemics
outbreak with the performance ∆h1,h2,TF (p1, p2,TF ) ≥ 1, see Figure 5(Left).
These configurations are quite similar with the combined effect of controls
h1 and h2, see Figure 5(Right). However, notice that controls h1 and h2
performed better than controls h1 and h2,TF , even for values of p1 up to 80%.
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Figure 5: Combined effect of intervention at HIV stages 1 and 2. (Left)
The performance ∆h1,h2,TF (p1, p2,TF ) of controls h1 and h2,TF with respect to
probabilities of treatment drop out at HIV stage 1, p1 and treatment drop out
at HIV stage 2 (with ART failure at stage 1), p2,TF . (Right) The performance
∆h1,h2 (p1, p2) of controls h1 and h2 with respect to probabilities of treatment
drop out at HIV stage 1, p1 and treatment drop out at HIV stage 2 (with no
ART at stage 1), p2. (Color figure online)
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Table 1: Description of the state variables and parameters of the model
State variables
S(t) Susceptible individuals at time t
ij(t, a) HIV individuals stage j at time t, in the stage for duration a (with no ART)
ij,TF (t, a) HIV individuals stage j with ART drop out at time t, in the stage for duration a
ij,TS(t, a) HIV individuals stage j with ART success at time t, in the stage for duration a
Fixed model parameters
Parameters Description; Value Ref
Λ Entering flux into S; 30 Ass
µ Exit rate of S; 1/30 PMs Ass
γ¯j Progression rate from stage j to j + 1; 1 PMs Ass
dj Death rate of HIV stage j = 1, 2; µ PMs Ass
d3 Death rate of HIV late stage; 0.14 per 1000 PYs+ µ [41]
ρ0 The rate of infectiousness; 2.48 Ass
Variable model parameters
Parameters Description; Reference value; {Range} Ref
T 10 Duration of HIV stage 1; 2.90; {1.23-6.00 } months [19]
T 20 Duration of HIV stage 2; 120; {108-180 } months [19]
β1 Transmission hazard stage 1; 276; {131-509} per 100 PYs [19]
β2 Transmission hazard stage 2; 10.6; {7.61-13.3} per 100 PYs [19]
β3 Transmission hazard stage 3; 0 per 100 PYs Ass
p1 Proba. of ART drop out at HIV stage 1;{0-1} Ass
p2 Proba. of ART drop out at stage 2 (with no ART at stage 1); {0-1} Ass
p2,TF Proba. of ART drop out at stage 2 (with ART failure at stage 1); {0-1} Ass
Cost coefficients in objective functional
B Balancing coefficient; {50-80} e [37]
Cj Balancing coefficients; {50-80} e [37]
PMs=person-months; PYs=person-years; Ass=Assumed.
6 Proof of Theorem 2.1
It is easy to check that operator A is a Hille-Yosida operator. Then standard
results apply to provide the existence and uniqueness of a mild solution to
(1.1) (we refer to [26, 38, 40] for more details). The Volterra formulation is
also standard and we refer to [22, 42] for more details.
For estimate 2., let ϕ0 ∈ X0+; then adding up the S equation together
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with the ij equations of (1.1) yields
P˙ (t) =
d
dt
(
S(t) +
3∑
j=1
∫ ∞
0
ij(t, a)da
)
≤ Λ− µP (t).
From where one deduces estimate 2.
The bounded dissipativity of the semiflow {Φ(t, ·)}t is a direct conse-
quence of estimate 2. It remains to prove the asymptotic smoothness. For
that ends, let B be a forward invariant bounded subset of X0+. According to
the results in [34] it is sufficient to show that the semiflow is asymptotically
compact on B. We first claim that
Claim 6.1 Let Assumption 1.1 be satisfied. Then, functions Ej’s are Lips-
chitz continuous on R+.
Therefore, let us consider a sequence of solutions (Sn, in1 , i
n
2 , i
n
3 )p that is equi-
bounded in X0+ and a sequence {tn}p such that tn → +∞. Let Inj (t) =∫∞
0
inj (t, σ)dσ, P
n(t) = Sn(t) +
∑3
j=1 I
n
j (t) and E
n
j (defined by (2.5)); with
j = 1, 2, 3; the corresponding sequences. Since Sn, P n, Inj ’s and E
n
j ’s are
uniformly bounded in the Lipschitz norm, the Arzela-Ascoli theorem implies
that, possibly along a subsequence, one may assume that Sn(t + tn) → S˜,
P n(t + tn) → P˜ and Enj (t + tn) → E˜j locally uniformly for for t ∈ R. It
remains to deal with the sequences {inj }n with j = 1, 2, 3. Denoting by
i˜n1 (t, ·) = in1 (t+ tn, ·) and using the Volterra formulation (2.4) it comes
i˜n1 (t, a) =
{
i10(a− t+ tn) D1(a)D1(a−t+tn) , for t+ tn < a,
Sn(t−a+tn)
Pn(t−a+tn)E
n
1 (t− a+ tn)D1(a), for t+ tn ≥ a.
Since S
n(t−a+tn)
Pn(t−a+tn)E
n
1 (t− a+ tn)D1(a) converges locally uniformly towards the
function S˜(t−a)
P˜ (t−a)E˜1(t− a)D1(a) as tn → +∞, we easily conclude that
in1 (tn, ·) = i˜n1 (0, ·)→
S˜(−·)
P˜ (−·)E˜1(−·)D1(·) in L
1(0,∞,R).
Similarly, we also find that
inj (tn, ·) = i˜nj (0, ·)→ E˜j(−·)Dj(·) in L1(0,∞,R), and for j = 2, 3.
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Item 3. follows.
For item 4. of the theorem, items 2. and 3. show that Φ is point
dissipative, eventually bounded on bounded sets, and asymptotically smooth.
Thus, item 4. follows from Theorem 2.33 of [36].
To complete the proof of the theorem, it remains to proof Claim 6.1.
Proof of Claim 6.1. Let t ∈ R+ and η > 0. Recalling (2.5) and set-
ting B1(t) =
∫∞
0
β(a)i1(t, a)da, B2(t) = ε
∫∞
0
β(a)i2(t, a)da and B3(t) =
δ
∫∞
0
β(a)i3(t, a)da, it comes
B1(t+ η)−B1(t) =
∫ η
0
β(a)i1(t+ η, a)da+
∫ ∞
η
β(a)i1(t+ η, a)da−
∫ ∞
0
β(a)i1(t, a)da
=
∫ η
0
β(a)i1(t+ η − a, 0)D1(a)da+
∫ ∞
η
β(a)i1(t+ η, a)da−
∫ ∞
0
β(a)i1(t, a)da.
Since the semiflow Φ is bounded and by Assumption 1.1 (item 2.), we can
find C > 0 such that
B1(t+ η)−B1(t) ≤C‖β‖2∞η +
∫ ∞
0
β(a+ η)i1(t+ η, a+ η)da−
∫ ∞
0
β(a)i1(t, a)da.
Then, recalling (2.4) and combining the integrals, we write
B1(t+ η)−B1(t) ≤C‖β‖2∞η +
∫ ∞
0
β(a+ η)
(
e−
∫ a+η
a (γ1(σ)+d1(σ))dσ − 1
)
i1(t, a)da
+
∫ ∞
0
(β(a+ η)− β(a)) i1(t, a)da.
Again by Assumption 1.1 (item 2.), we have 1 ≥ e−
∫ a+η
a (γ1(σ)+d1(σ))dσ ≥
e−(‖γ1‖∞+‖d1‖∞)η ≥ 1−(‖γ1‖∞+‖d1‖∞)η. Therefore, β(a+η)
∣∣∣e− ∫ a+ηa (γ1(σ)+d1(σ))dσ − 1∣∣∣ ≤
‖β‖∞(‖γ1‖∞ + ‖d1‖∞)η and since the semiflow Φ is bounded we can find a
positive constant C such that
B1(t+ η)−B1(t) ≤C‖β‖2∞η + C‖β‖∞(‖γ1‖∞ + ‖d1‖∞)η
+
∫ ∞
0
(β(a+ η)− β(a)) i1(t, a)da.
Next, using Assumption 1.1 (item 3.) and the boundedness of the semiflow,
we find a positive constant C such that∫ ∞
0
|β(a+ η)− β(a)| i1(t, a)da ≤ Cη.
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From where, we find C1 > 0 such that
|B1(t+ η)−B1(t)| ≤ C1η.
Using the same arguments, we find C2 > 0 such that
|B2(t+ η)−B2(t)| ≤ C2η.
Since E1 = B1 +B2 +B3, combining the two previous inequalities, it follows
that E1 is Lipschitz on R+. Similarly, E2 and E3 are also Lipschitz and this
ends the proof of the claim.
7 Proof of Theorem 2.3
First, let us introduce some useful technical materials by establishing some
properties of the complete solutions of system (1.1).
7.1 Technical materials
The first result deals with spectral properties of the linearized semiflow Φ
at a given equilibrium point ϕ∗ = (v∗, 0R3 , u∗1, u
∗
2, u
∗
3) ∈ X0+ . The linearized
system at ϕ∗ reads
dϕ(t)
dt
= (A+ F ∗)ϕ(t),
where F ∗ is a linear bounded operator given by
F ∗ (v, 0R3 , u1, u2, u3)
T =
( −W∗,W∗, ∫∞
0
γ1(a)u1(a)da,
∫∞
0
γ2(a)u2(a)da, 0, 0, 0
)T
,
wherein
W∗ = 1(
v∗ + A
∗)2
[
vA
∗
B
∗ − v∗B∗
∫ ∞
0
3∑
j=1
uj(a)da
+v∗
(
v∗ + A
∗)∫ ∞
0
β(a) (u1(a) + εu2(a) + δu3(a)) da
]
,
and
A
∗
=
∫ ∞
0
3∑
j=1
u∗j(a)da,
B
∗
=
∫ ∞
0
β(a) (u∗1(a) + εu
∗
2(a) + δu
∗
3(a)) da.
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Lemma 7.1 Let us set Σ = {λ ∈ C : Re(λ) > −µ}. The spectrum σ (A+ F ∗)∩
Σ consists of a point spectrum and one has
σ (A+ F ∗) ∩ Σ = {λ ∈ Σ : χ(λ, ϕ∗) = 0}
where the function χ(·, ϕ∗) : Σ→ C is defined by
χ(·, ϕ∗) = 1− Q
∗(·)(·+ µ)
A
∗
B
∗
+
(
v∗ + A
∗)2
(·+ µ)
, (7.13)
and wherein
Q∗(λ) =− v∗B∗ (Dλ1 +Dλ2 Γ1(λ) +Dλ3 Γ1(λ)Γ2(λ))
+ v∗
(
v∗ + A
∗)
(Ω1(λ) + εΩ2(λ)Γ1(λ) + δΩ3(λ)Γ1(λ)Γ2(λ)) ,
Ωj(λ) =
∫ ∞
0
β(a)Dj(a)e
−λada, Γj(λ) =
∫ ∞
0
γj(a)Dj(a)e
−λada,
Dλj =
∫ ∞
0
Dj(a)e
−λada.
Proof. Let us denote by A0 the part of A in X0. Then it is the infinitesimal
generator of a C0-semigroup on X0 denoted by {TA0(t)}t. We can easily check
that the essential growth rate of this semigroup satisfies ω0,ess(A0) ≤ −µ.
Since operator F ∗ is compact, results in [11, 39] apply and ensure that the
essential growth rate of {T(A+F ∗)0(t)}t, the C0-semigroup generated by the
part of A+F ∗ in X0 is such that ω0,ess(A+F ∗)0 ≤ −µ. Applying the results
in [27], the latter inequality ensures that σ(A+F ∗)∩Σ is only composed of a
point spectrum of (A+ F ∗). The derivation of the characteristic equation is
standard and we refer to [6, 28]. Indeed, let us first notice that A is a Hille-
Yosida operator on X , meaning that [−µ,∞) ⊂ σ(A) and for z > −µ one
has ‖ (zI − A)−1 ‖ ≤ (z + µ)−1. Therefore, for λ ∈ C such that Re(λ) > −µ
it is easily checked that [λI− (A+F ∗)]−1 = (λI−A)−1[I−F ∗(λI−A)−1]−1.
That is to say
λ ∈ σ(A+ F ∗)⇔ 1 ∈ σ(F ∗(λI − A)−1).
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We also have
[I − F ∗(λI − A)−1] (α1, α2, α3, α4, w1, w2, w3)T = (v, 0R3 , u1, u2, u3)T ⇔
α1 + W˜∗ = v,
α2 − W˜∗ = 0,
α3 −
∫∞
0
γ1w˜1(a)da = 0,
α4 −
∫∞
0
γ2w˜2(a)da = 0,
w1 = u1;w2 = u2;w3 = u3,
(7.14)
where w˜j(a) = αj+1Dj(a)e
−λa + gj(λ, a); gj(λ, a) =
∫ a
0
uj(s)
Dj(a)
Dj(s)
e−λ(a−s)ds,
and
W˜∗ = α1A
∗
B
∗(
v∗ + A
∗)2
(λ+ µ)
+
1(
v∗ + A
∗)2
[
−v∗B∗
∫ ∞
0
3∑
j=1
w˜j(a)da
+v∗
(
v∗ + A
∗)∫ ∞
0
β(a) (w˜1(a) + εw˜2(a) + δw˜3(a)) da
]
.
First, from (7.14), we have
α3 =α2Γ1(λ) +
∫ ∞
0
γ1(a)g1(λ, a)da,
α4 =α2Γ1(λ)Γ2(λ) + Γ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
γ2(a)g2(λ, a)da.
From where∫ ∞
0
3∑
j=1
w˜j(a)da =
(
Dλ1 +D
λ
2 Γ1(λ) +D
λ
3 Γ1(λ)Γ2(λ)
)
α2
+Dλ3
(
Γ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
γ2(a)g2(λ, a)da
)
+Dλ2
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
3∑
j=1
gj(λ, a)da,
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and∫ ∞
0
β(a) (w˜1(a) + εw˜2(a) + δw˜3(a)) da = (Ω1(λ) + εΩ2(λ)Γ1(λ) + δΩ3(λ)Γ1(λ)Γ2(λ))α2
+ δΩ3(λ)
(
Γ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+ ε
∫ ∞
0
γ2(a)g2(λ, a)da
)
+ εΩ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
β(a) (g1(λ, a) + εg2(λ, a) + δg3(λ, a)) da.
From the tow previous equality, W˜∗ rewrites
W˜∗ = α1A
∗
B
∗(
v∗ + A
∗)2
(λ+ µ)
+
1(
v∗ + A
∗)2 [Q∗α2 +R∗(λ, u)] ,
with
R∗(λ, u) = −v∗B∗Dλ3
(
Γ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
γ2(a)g2(λ, a)da
)
− v∗B∗Dλ2
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
3∑
j=1
gj(λ, a)da
+ v∗
(
v∗ + A
∗)
δΩ3(λ)
(
Γ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+ ε
∫ ∞
0
γ2(a)g2(λ, a)da
)
+ v∗
(
v∗ + A
∗)
εΩ2(λ)
∫ ∞
0
γ1(a)g1(λ, a)da+
∫ ∞
0
β(a) (g1(λ, a) + εg2(λ, a) + δg3(λ, a)) da.
From the two first equations of (7.14), a straightforward computation
gives
α1 = −
1 + A∗B∗(
v∗ + A
∗)2
(λ+ µ)

−1
Q∗(λ)α2(
v∗ + A
∗)2 +G(λ, v, u),
α2
1− Q∗(λ)(λ+ µ)
A
∗
B
∗
+
(
v∗ + A
∗)2
(λ+ µ)
 = R∗(λ, u)(
v∗ + A
∗)2 + A
∗
B
∗
G(λ, v, u)(
v∗ + A
∗)2
(λ+ µ)
with
G(λ, v, u) =
1 + A∗B∗(
v∗ + A
∗)2
(λ+ µ)

−1v − R∗(λ, u)(
v∗ + A
∗)2
 .
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By setting
χ(λ, ϕ∗) = 1− Q
∗(λ)(λ+ µ)
A
∗
B
∗
+
(
v∗ + A
∗)2
(λ+ µ)
,
we can then isolate α2 (and then α1, α3, α4) if and only if χ(λ, ϕ
∗) 6= 0.
The next results relies on some properties of the complete solutions of
system (1.1).
Lemma 7.2 Set y0 = (S0, i10, i20, i30) and let {y(t) = (S(t), i1(t, ·), i2(t, ·), i3(t, ·))}t∈R ⊂
X0+ a complete solution of (1.1) passing through y0. Then, S(t) is strictly
positive for all t and either E1 is identically zero or E1(t) is positive for all
t.
Proof. Assume that there exists t1 ∈ R such that S(t1) = 0. Then, the S-
equation of (1.1) gives S˙(t1) > 0 meaning that we can find δ > 0 sufficiently
small such that S(t1 − δ) < 0. A contradiction with the fact that the total
trajectory y(t) lies in X0+ in for all t ∈ R.
Next, let us notice that since y is a complete solution, it comes from the
Volterra formulation
i1(t, a) =
S(t− a)
P (t− a)E1(t− a)D1(a),
ij(t, a) =Ej(t− a)Dj(a), j = 2, 3; and ∀(t, a) ∈ R× [0,∞).
From above formulation, we can observe that ij(t, a) = ij(t − a, 0)Dj(a),
j = 1, 2, 3. Moreover, Ej+1(t) =
∫∞
0
γj(a)Dj(a)Ej(t − a)da, with j = 1, 2.
Therefore, a straightforward computation gives
E1(t) =
∫ ∞
0
β(a)D1(a)
S(t− a)
P (t− a)E1(t− a)da
+ ε
∫ ∞
0
∫ ∞
0
β(a)D2(a)D1(η)γ1(η)
S(t− a− η)
P (t− a− η)E1(t− a− η)dηda
+ δ
∫ ∞
0
∫ ∞
0
∫ ∞
0
β(a)D3(a)D2(η)γ2(η)D1(s)γ1(s)
S(t− a− η − s)
P (t− a− η − s)E1(t− a− η − s)dsdηda.
(7.15)
Then, due to Assumption 1.1, (7.15) gives that either E1 is identically
zero or E1(t) takes on positive values for all t ∈ R.
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7.2 Proof of Theorem 2.3 item 1
Let y0 ∈ B and let Φ(t, y0) = (S(t), i1(t, ·), i2(t, ·), i3(t, ·)) a complete solu-
tion in B passing through y0 at t = 0. By setting Ej = supt∈REj(t) we
successively obtain for all t ∈ R
E2(t) ≤E1Γ1,
E3(t) ≤E1Γ1Γ2,
E1(t) ≤E1 (Ω1 + εΓ1Ω2 + δΓ1Γ2Ω3 ) .
Taking the supremum on the left-hand side of the E1 inequality it comes
E1 ≤ E1R0. Then since E1 is non-negative and R0 < 1 it follows E1 = 0.
Similarly, we also find that E2 = E3 = 0. Therefore, the attractor is a
compact invariant subset of the space R × {0} × {0} × {0}. Since the only
such set is the singleton containing the disease-free equilibrium E0, this ends
the proof of the first part of item 1 of Theorem 2.3.
It remains to prove that E0 is unstable when R0 > 1. Notice that the
function χ(·, E0) = 1 − [Ω1(·) + εΩ2(·)Γ1(·) + δΩ3(·)Γ1(·)Γ2(·)] provided by
(7.13) at E0 is a non-decreasing function on R+ such that χ(0, E0) = 1−R0 <
0 and limλ→+∞ χ(λ,E0) > 0. As consequence, there exists strictly positive
eigenvalue , i.e. ∃λ0 ∈ R∗+ such that χ(λ0, E0) = 0. This ends the second
part of item 1 of Theorem 2.3.
7.3 Proof of Theorem 2.3 item 2(i) and 2(ii)
Let us start by the proof of item 2(i). By Lemma 7.1 the spectrum of the
linearized semiflow {Φ(t, ·)}t at the endemic equilibrium E∗ is characterized
by the following equation, with Re(λ) > −µ:
(Ω1(λ) + εΩ2(λ)Γ1(λ) + δΩ3(λ)Γ1(λ)Γ2(λ)) = 1 +
A
∗
S∗
+
A
∗
B
∗
S∗
(
S∗ + A
∗)
+
B
∗ (
Dλ1 +D
λ
2 Γ1(λ) +D
λ
3 Γ1(λ)Γ2(λ)
)
S∗ + A
∗ .
(7.16)
Since A
∗
/S∗ = R0 − 1, we obtain from the right hand side of (7.16)
|RHS of (7.16)| > R0, ∀λ ∈ C : Re(λ) > −µ. (7.17)
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Now by contradiction let us assume that there exists λ0 ∈ C such that
Re(λ0) > 0. Then, the left hand side of (7.16) gives
|LHS of (7.16)| < Ω1(0) + εΩ2(0)Γ1(0) + δΩ3(0)Γ1(0)Γ2(0) = R0. (7.18)
A contradiction holds from (7.17) and (7.18). This ends the proof of Theorem
2.3 item 2(i).
Next, we deal with the proof of Theorem 2.3 item 2(ii). A trivial solution
of (1.1) satisfying these initial conditions is given by i1(t, ·) = i2(t, ·) =
i3(t, ·) = 0 where S is such that S˙ = Λ − µS. This trivial solution tends
exponentially to E0. Since solutions to the initial value problem are unique,
statement 2(ii) of the theorem follows.
7.4 Proof of Theorem 2.3 item 2(iii)
We assume that the support of at least one of ij0’s has positive measure, and
therefore E1(t) =
∫∞
0
β(a) (i1(t, a) + εi2(t, a) + δi3(t, a)) da takes on positive
values for arbitrarily large values of t (by Lemma 7.2). Furthermore, Claim
6.1 gives that E1 is Lipschitz, it follows that E1 is positive on a set of positive
measure. In the sequel, when that exists, we set for a given function h:
h∞ = lim supt→∞ h(t) and h∞ = lim inft→∞ h(t).
For η0 > 0, there exists t1 ∈ R such that E1(t) ≤ E∞1 + η02 for all t ≥ t1.
Then, it follows from the S-equation of (1.1) that S∞ ≥ Λ
(
µ+
E∞1
P∞ +
η0
2
)−1
.
Thus, there exists t2 ≥ t1 such that
S(t) ≥ Λ
(
µ+
E∞1
P∞
+
η0
2
)−1
, ∀t ≥ t2. (7.19)
We perform a time-shift of t2 on the solution being studied, i.e. we replace
the initial condition y0 with y1 = Φ(t2, y0). The solution passing through y1
satisfies equations (7.15) and (7.19) for all t, and the bounds E∞1 and P∞ > 0
remain valid. Note that (7.15) rewrites
E1(t) =
∫ ∞
0
β(a)D1(a)
S(t− a)
P (t− a)E1(t− a)da
+ ε
∫ ∞
0
S(t− τ)
P (t− τ)E1(t− τ)
∫ τ
0
β(a)D2(a)D1(τ − a)γ1(τ − a)dadτ
+ δ
∫ ∞
0
S(t− τ)
P (t− τ)E1(t− τ)
∫ τ
0
∫ τ−a
0
β(a)D3(a)D2(η)γ2(η)D1(τ − a− η)γ1(τ − a− η)dηdadτ.
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From where
E1(t) ≥ K
∫ t
0
u(τ)E1(t− τ)dτ, (7.20)
whereinK = µ
(
µ+
E∞1
P∞ +
η0
2
)−1
and u(τ) = β(τ)D1(τ)+ε
∫ τ
0
β(a)D2(a)D1(τ−
a)γ1(τ−a)da+δ
∫ τ
0
∫ τ−a
0
β(a)D3(a)D2(η)γ2(η)D1(τ−a−η)γ1(τ−a−η)dηda.
Taking the Laplace transform of each side of inequality (7.20) converts the
convolution to a product and we obtain for λ ∈ C
Kû(λ)Ê1(λ) ≤ Ê1(λ).
Since E1 is positive on a set of positive measure then, Ê1 is strictly positive
and the last inequality gives
K
∫ ∞
0
e−λτ
(
β(τ)D1(τ) + ε
∫ τ
0
β(a)D2(a)D1(τ − a)γ1(τ − a)da
+δ
∫ τ
0
∫ τ−a
0
β(a)D3(a)D2(η)γ2(η)D1(τ − a− η)γ1(τ − a− η)dηda
)
dτ ≤ 1.
(7.21)
Changing the order of integration from the left hand side of (7.21), it comes
successively
LHS of (7.21) =K
∫ ∞
0
e−λτβ(τ)D1(τ)dτ +Kε
∫ ∞
0
∫ ∞
0
e−λ(a+σ)β(a)D2(a)D1(σ)γ1(σ)dσda
+Kδ
∫ ∞
0
∫ ∞
0
∫ ∞
0
e−λ(τ+a+η)β(a)D3(a)D2(η)γ2(η)D1(τ)γ1(τ)dτdηda.
From where (7.21) rewrites
K
∫ ∞
0
e−λτβ(τ)D1(τ)dτ +Kε
∫ ∞
0
∫ ∞
0
e−λ(a+σ)β(a)D2(a)D1(σ)γ1(σ)dσda
+Kδ
∫ ∞
0
∫ ∞
0
∫ ∞
0
e−λ(τ+a+η)β(a)D3(a)D2(η)γ2(η)D1(τ)γ1(τ)dτdηda ≤ 1.
Taking limits as η0 and λ tend to zero in the previous inequality, it comes
µ
µ+
E∞1
P∞
R0 ≤ 1 i.e. E
∞
1
P∞
≥ µ (R0 − 1) .
Then, we have the following.
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Proposition 7.3 If R0 > 1, then the semiflow {Φ(t, y0)}t is uniformly
weakly persistent in the sense that there exists ν0 > 0 such that
lim sup
t→∞
∫ ∞
0
β(a) (i1(t, a) + εi2(t, a) + δi3(t, a)) da ≥ ν0.
Therefore, the uniform persistence of the semiflow follows from the con-
tinuity of E1 (see Claim 6.1), Theorem 2.1 statement 4, Lemma 7.2, the
uniform weakly persistence of the semiflow (see Proposition 7.3) and Theo-
rem 5.2 in [36]. This ends the proof of Theorem 2.3 item 2(iii).
8 Existence of an optimal control
By setting V = {1, 1.TF, 2, 2.TF, 3, 1.TS, 2.TS}, let us consider a control h ∈
U and denote by wh(t, a) = (Sh(t), (ihj (t, a))j∈V), (resp. λh = (λhS(t), (λhj (t, a))j∈V)),
the corresponding state, (resp. adjoint), vector variable given by (4.8) and
(4.10)-(4.11). Let us define the map L : L1((0, Tf ),R3) −→ L∞((0, Tf ),R3)
by L(u1, u2, u3) = (L1u1,L2u2,L2.TFu3), where
Lju =

0, if u < 0,
u, if 0 ≤ u < hmaxj ,
hmaxj , if u ≥ hmaxj , j ∈ {1; 2; 2.TF}.
By setting X := (0, Tf ) ×
(
QTf
)7
with QTf = (0, Tf ) × (0,∞), we define
the norms ‖ · ‖L1(X ) and ‖ · ‖L∞(X ) such that for a given vector function
(y, x) := (y, (xj)j=1,...,7),
‖(y, x)‖L1(X ) =
∫ Tf
0
|y(t)|dt+
7∑
j=1
∫ Tf
0
∫ ∞
0
|xj(t, a)|dtda,
‖(y, x)‖L∞(X ) = sup
t∈[0,Tf ]
|y(t)|+
7∑
j=1
sup
t∈[0,Tf ]
∫ ∞
0
|xj(t, a)|da.
In the same way, define the norms ‖.‖L1(QTf ) and ‖.‖L∞(QTf ). We embed
our optimal problem in the space L1(0, Tf ) by defining the function
J (h) =
{
J(h), if h ∈ U ,
+∞, if h /∈ U .
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To prove the existence of the optimal control, let us introduce the first
preliminary result.
Lemma 8.1 Let Tf be sufficiently small.
1. The map h ∈ U → wh ∈ L1(X ) is Lipschitz for the norms ‖ · ‖L1 and
‖ · ‖L∞ in the following ways:
‖wh−wv‖L1(X ) ≤ TfC‖h−v‖L1(0,Tf ) and ‖wh−wf‖L∞(X ) ≤ TfC‖h−f‖L∞(0,Tf )
for all h, f ∈ U and where C > 0 is a constant.
2. For h ∈ U , the adjoint system (4.10)-(4.11) has a weak solution λh in
L∞(X ) such that
||λh − λf ||L∞(X ) ≤ TfC||h− f ||L∞(0,Tf ),
for all h, f ∈ U and C > 0.
3. The functional J (h) is lower semicontinuous with respect to L1(0, Tf )
convergence.
Proof. Recalling E1(t) =
∫∞
0
β(a) [i1 + i1,TF + ε(i2 + i2,TF ) + δi3] (t, a)da,
and since the total population P · is bounded by positive constants, we easily
find a constant C0 > 0 such that∣∣∣∣∣Eh1 (t)P h(t) − Ef1 (t)P f (t)
∣∣∣∣∣ ≤ C0‖β‖∞ ∑
v∈{i1,i1,TF ,i2,i2,TF ,i3}
‖vh(t, ·)− vf (t, ·)‖L1(0,∞).
Moreover, by using the same arguments as in item 2. of Theorem 2.1, we can
find a positive constantM0 such that |Sh(t)|+
∑
v∈{i1,i1,TF ,i2,i2,TF ,i3} ‖vh(t, ·)‖L1(0,∞) ≤
M0 for all h ∈ U and a.e. t.
Then, integrating the S-component of (4.6) it comes
|Sh(t)− Sf (t)| ≤ ‖β‖∞C0M0
∫ t
0
e−µτ |Sh(τ)− Sf (τ)|dτ
+ ‖β‖∞C0M0
∫ t
0
e−µτ
∑
v∈{i1,i1,TF ,i2,i2,TF ,i3}
‖vh(τ, ·)− vf (τ, ·)‖L1(0,∞)dτ.
(8.22)
Moreover, the Volterra integral formulation of system (4.8) gives for i1-
equation
ih1(t, a) =
{
i10(a− t) D1(a)D1(a−t) , for t < a,
(1− h1(t− a)) Sh(t−a)Ph(t−a)Eh1 (t− a)D1(a), for t ≥ a
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From where,
‖ih1(t, ·)− if1(t, ·)‖L1(0,∞) ≤M20‖β‖∞‖h1 − f1‖L1(0,Tf )
+ C0M0Tf‖β‖∞
 ∑
v∈{i1,i1,TF ,i2,i2,TF ,i3}
‖vh(t, ·)− vf (t, ·)‖L1(0,∞) + |Sh(t)− Sf (t)|
 .
(8.23)
Therefore, applying same arguments for i1,TF , i2, i2,TF and i3 as for es-
timates (8.23) and combining with (8.22), it follows that for Tf sufficiently
small,
||wh − wv||L1(X ) ≤ TfC||h− v||L1(0,Tf ).
The same arguments is then apply for the norm L∞ and for item 2. It remains
to prove item 3.
We suppose that hn := (h1n, h2n, h2n,TF )→ h := (h1, h2, h2,TF ) in L1(0, Tf ).
Possibly along a subsequence and using the same notation, h2n → h2 a.e. on
(0, Tf ) by (see [14], p.21). By Lebesgue’s dominated convergence theorem,
it comes lim
n→∞
||h2n||L1(0,Tf ) = ||h2||L1(0,Tf ). We have the similar arguments
for ||f 2||L1(0,Tf ). These handle the convergence of the squared terms in the
functional.
Next, we illustrate the convergence of one term in the functional,
||Bγ2(ihn2 − ih2)||L1(QTf ) ≤ ||B||∞||γ2||∞||whn − wh||L1(X )
≤ CTf ||hn − h||L1(0,Tf ).
Therefore,
|J (hn)− J (h)| ≤ CTf ||hn − h||L1(0,Tf ).
From where we deduce the lower semi-continuity, J (h) ≤ lim inf
n→∞
J (hn).
The functional J : (0, Tf ) → (−∞,∞] is lower semi-continuous with re-
spect to strong L1 convergence but not with respect to weak L1 convergence.
Thus, in general it does not attain its infimum on (0, Tf ). Thus we circum-
vent this situation by using the Ekerland’s variational principle (see [13]):
for δ > 0, there exists hδ in L
1(0, Tf ) such that
J (hδ) ≤ inf
h∈U
J (h) + δ, (8.24)
J (hδ) = min
h∈U
{
J (h) +
√
δ||hδ − h||L1(0,Tf )
}
. (8.25)
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Note that, by (8.25), the perturbed functional
Jδ(h) = J (h) +
√
δ||hδ − h||L1(0,Tf )
attains its infimum at hδ. By the same argument as in Section 4.3, and using
the projection map L on U , it comes that
Lemma 8.2 If hδ is an optimal control minimizing the functional Jδ(h),
then
hδ = L
(
hˆ1(λ
hδ) +
√
δpiδ1
2C1
, hˆ2(λ
hδ) +
√
δpiδ2
2C2
, hˆ2,TF (λ
hδ) +
√
δpiδ3
2C3
)
;
where piδj ∈ L∞(0, Tf ), with |piδj (·)| ≤ 1 and
hˆ1(λ
hδ) =
(
λi1(t, 0)− p1λi1,TF (t, 0)− (1− p1)λi1,TS(t, 0)
)
2C1
SEhδ1
P hδ
,
hˆ2(λ
hδ) =
(
λi2(t, 0)− p2λi2,TF (t, 0)− (1− p2)λi2,TS(t, 0)
)
2C2
Ehδ2 ,
hˆ2,TF (λ
hδ) =
(
λi2(t, 0)− p2,TFλi2,TF (t, 0)− (1− p2,TF )λi2,TS(t, 0)
)
2C3
Ehδ2,TF .
By Lemmas 8.1 and 8.2, we are now ready to prove the existence and
uniqueness of an optimal controller. Namely, we have the following theorem.
Namely, we have the following result.
Theorem 8.3 If
Tf
2
∑3
j=1
1
Cj
is sufficiently small, there exists one and only
one optimal controller h∗ in U minimizing J (h).
Proof. We star with the uniqueness by defining F : U −→ U by
F(h) = L
(
hˆ1(λ
h), hˆ2(λ
h), hˆ2,TF (λ
h)
)
wherein wh and λh are state and adjoint solutions corresponding to h as in
previous sections. Using the Lipschitz properties of wh and λh (see Lemma
8.1), for h, h¯ ∈ U , we find C > 0 such that for Tf sufficiently small
‖L1(h1)− L1(h¯1)‖L∞(0,Tf ) ≤
C0 max (M0,M
2
0 )
2C1
×
(
‖wh − wh¯‖L∞(QTf ) + ‖λh − λh¯‖L∞(QTf )
)
≤ CTf
2C1
‖h− h¯‖L∞(0,Tf ).
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Applying the same arguments for L2 and L2,TF , it comes
‖F(h)−F(h¯)‖L∞(0,Tf ) ≤ CTf‖h− h¯‖L∞(0,Tf )
( 1
2C1
+
1
2C2
+
1
2C3
)
(8.26)
where the positive constant C depends on the L∞ bounds on the state and
the adjoint solutions and Lipschitz constants. Therefore, if Tf <
2
C
( 1
C1
+ 1
C2
+
1
C3
)−1, thus the map F has a unique fixed point h∗.
It remains to prove that this fixed point is an optimal controller. For that
ends, we used the approximate minimizers hδ from Ekerland’s variational
principle. From Lemma 8.2 and the contraction property of F , we have
∥∥∥F(hδ)− L(hˆ1(λhδ) + √δpiδ12C1 , hˆ2(λhδ) + √δpiδ22C2 , hˆ2,TF (λhδ) + √δpiδ32C3 )∥∥∥L∞(0,Tf ) =∥∥∥L(hˆ1(λhδ), hˆ2(λhδ), hˆ2,TF (λhδ))
−L
(
hˆ1(λ
hδ) +
√
δpiδ1
2C1
, hˆ2(λ
hδ) +
√
δpiδ2
2C2
, hˆ2,TF (λ
hδ) +
√
δpiδ3
2C3
)∥∥∥
L∞(0,Tf )
≤∑3j=1 ∥∥∥√δpiδj2Cj ∥∥∥L∞(0,Tf ) ≤ √δ
(
1
2C1
+ 1
2C2
+ 1
2C3
)
.
(8.27)
Consequently, from (8.26) and (8.27), we have
‖h∗ − hδ‖L∞(0,Tf ) =∥∥∥F(h∗)− L(hˆ1(λhδ) + √δpiδ12C1 , hˆ2(λhδ) + √δpiδ22C2 , hˆ2,TF (λhδ) + √δpiδ32C3 )∥∥∥L∞(0,Tf )
≤ ‖F(h∗)−F(hδ)‖L∞(0,Tf )
+
∥∥∥F(hδ)− L(hˆ1(λhδ) + √δpiδ12C1 , hˆ2(λhδ) + √δpiδ22C2 , hˆ2,TF (λhδ) + √δpiδ32C3 )∥∥∥L∞(0,Tf )
≤
(
CTf‖h∗ − hδ‖L∞(0,Tf ) +
√
δ
)(
1
2C1
+ 1
2C2
+ 1
2C3
)
.
Since CTf
(
1
2C1
+ 1
2C2
+ 1
2C3
)
is sufficiently small, it comes
‖h∗ − hδ‖L∞(0,Tf ) ≤
√
δ
[
1− CTf
3∑
j=1
1
2Cj
]−1 3∑
j=1
1
2Cj
,
which gives hδ −→ h∗ in L∞(0, Tf ) (as δ −→ 0) and by (8.24)
J (h∗) = inf
h∈U
J (h).
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9 Basic reproduction number of model (1.1)
Let N(t) = S(t)
P (t)
E1(t) be the density of newly HIV infected at time t. Then
from (1.1) one has
N(t) = E1(t) =
∫ ∞
0
β(a)(i1(t, a) + εi2(t, a) + δi3(t, a))da
where ij(t, a)’s are given by the resolution of the linearized system (1.1) at
the disease free equilibrium E0. Then the Volterra formulation (2.4) yields
N(t) =
∫ t
0
β(a) (D1(a)E1(t− a) + εD2(a)E2(t− a) + δD3(a)E3(t− a)) da+N0(t),
(9.28)
withN0(t) =
∫∞
t
β(a)
(
i10(a− t) D1(a)D1(a−t) + εi20(a− t)
D2(a)
D2(a−t) + δi30(a− t)
D3(a)
D3(a−t)
)
da.
Further, we have
E2(t) =
∫ t
0
γ1(a)D1(a)E1(t− a)da+H2(t),
E3(t) =
∫ t
0
γ2(a)D2(a)E2(t− a)da+
∫ ∞
t
γ2(a)i20(a− t) D2(a)
D2(a− t)da
=
∫ t
0
E1(t− a)U(a)da+H3(t),
with H2(t) =
∫∞
t
γ1(a)i10(a−t) D1(a)D1(a−t)da, H3(t) =
∫ t
0
γ2(a)D2(a)H2(t−a)da+∫∞
t
γ2(a)i20(a− t) D2(a)D2(a−t)da, and U(a) =
∫ a
0
γ1(a−σ)D1(a−σ)γ2(σ)D2(σ)dσ.
Therefore,∫ t
0
β(a)D2(a)E2(t− a)da =
∫ t
0
E1(t− a)
∫ a
0
D1(a− σ)γ1(a− σ)β(σ)D2(σ)dσda
+
∫ t
0
β(a)D2(a)H2(t− a)da,
and∫ t
0
β(a)D3(a)E3(t− a)da =
∫ t
0
E1(t− a)
∫ a
0
U(a− σ)β(σ)D3(σ)dσda
+
∫ t
0
β(a)D3(a)H3(t− a)da.
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Consequently, (9.28) rewrites
N(t) =
∫ t
0
K(a)E1(t− a)da+N0(t)
+ ε
∫ t
0
β(a)D2(a)H2(t− a)da+ δ
∫ t
0
β(a)D3(a)H3(t− a)da,
wherein
K(a) = β(a)D1(a)+ε
∫ a
0
D1(a−σ)γ1(a−σ)β(σ)D2(σ)dσda+δ
∫ a
0
U(a−σ)β(σ)D3(σ)dσ.
From the above formulation, the basic reproduction number is calculated as
R0 =
∫ ∞
0
K(a)da
=
∫ ∞
0
β(a)D1(a)da+ ε
∫ ∞
0
∫ a
0
D1(a− σ)γ1(a− σ)β(σ)D2(σ)dσda
+ δ
∫ ∞
0
∫ a
0
β(σ)D3(σ)U(a− σ)dσda
=
∫ ∞
0
β(a)D1(a)da+ ε
∫ ∞
0
β(a)D2(a)
∫ ∞
a
D1(σ − a)γ1(σ − a)dσda
+ δ
∫ ∞
0
β(a)D3(a)
∫ ∞
a
U(σ − a)dσda
=
∫ ∞
0
β(a)D1(a)da+ ε
∫ ∞
0
β(a)D2(a)da
∫ ∞
0
D1(σ)γ1(σ)dσ
+ δ
∫ ∞
0
β(a)D3(a)da
∫ ∞
0
γ2(σ)D2(σ)dσ
∫ ∞
0
γ1(τ)D1(τ)dτ,
=Ω1 + εΓ1Ω2 + δΓ1Γ2Ω3.
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